CIK 0000906709
- Non-accelerated filer
- Smaller reporting company
NEKTAR THERAPEUTICS
Sign in to watch- Ticker
- NKTR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943134940
- Phone
- +1 415-482-5300
- Business address
- 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
- Former names
- INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
- 4 Open-market sale President & CEO sold 87,500 shares at $12.35 ($1,080,625)
- 4 Grant or award SVP & Chief Accounting Officer acquired 15,000 shares (grant or award)
- 4 Grant or award President & CEO acquired 55,000 shares (grant or award)
- 4 Grant or award SVP & Chief Operating Officer acquired 20,000 shares (grant or award)
- 4 Grant or award SVP & Chief Financial Officer acquired 20,000 shares (grant or award)
- 4 Grant or award SVP Pharma Dev & Mfg Ops acquired 15,000 shares (grant or award)
- 4 Grant or award SVP & Chief Medical Officer acquired 20,000 shares (grant or award)
- 4 Grant or award SVP & Chief Scientific Officer acquired 17,500 shares (grant or award)
- 4 Open-market sale President & CEO sold 87,500 shares at $12.24 ($1,071,000)
- 4 Open-market sale SVP & Chief Accounting Officer sold 1,986 shares at $13.96 ($27,725)
- 4 Open-market sale President & CEO sold 93,458 shares at an average $13.88 ($1,296,799)
- 4 Open-market sale SVP & Chief Operating Officer sold 1,654 shares at $13.96 ($23,090)
- 4 Open-market sale SVP & Chief Financial Officer sold 1,654 shares at $13.96 ($23,090)
- 4 Open-market sale SVP Pharma Dev & Mfg Ops sold 1,654 shares at $13.96 ($23,090)
- 4 Open-market sale SVP & Chief Medical Officer sold 848 shares at $13.96 ($11,838)
- 4 Open-market sale SVP & Chief Scientific Officer sold 670 shares at $13.96 ($9,353)
- 4 Open-market buy Director bought 15,000 shares at $13.50 ($202,500)
- 4 Open-market sale President & CEO sold 87,500 shares at $17.06 ($1,492,750)
- 4 Exercise or conversion Director acquired 46,000 shares (option exercise)
- 4 Grant or award Director acquired 8,000 shares (grant or award)
Page 23 of 49 · 970 filings